住院老年人衰弱评估:不同衰弱测量工具对短期和长期结局的预测比较
前瞻性队列研究纳入210例住院老年患者(平均年龄89.4±4.6岁,女性69.5%),以衰弱指数(FI)为金标准,比较FRAIL、临床衰弱量表(CFS)和Tilburg衰弱指标(TFI)识别衰弱及预测12个月不良结局的能力。CFS与FI一致性最高(AUC 0.91),仅FRAIL与院内死亡升高相关,CFS对12个月死亡及机构化复合结局的预测风险最大。
要点
- CFS与FI一致性最佳(AUC 0.91,95%CI 0.87-0.95)。
- 仅FRAIL与院内死亡升高相关(6.7% vs 1.0%,P=.031)。
- CFS预测12个月死亡风险最高(OR 5.78,95%CI 3.19-10.48)。
核心结论
- 在急性病住院老年人中衰弱评估工具仍有实用价值,FRAIL与院内死亡风险关联最强,而CFS对12个月死亡和机构化风险预测最好。
研究设计与样本
- 前瞻性队列研究,纳入210例入住1300张床位三级医院老年医学科的患者,平均年龄89.4±4.6岁,女性占69.5%。
- 以衰弱指数(FI)为金标准,比较FRAIL、CFS和TFI的诊断性能和12个月结局预测能力。
主要发现
- 衰弱患病率分别为FI 87.1%、CFS 81.0%、TFI 80.0%、FRAIL 50.0%。
- 各工具相对FI的AUC从0.81(95%CI 0.72-0.90,FRAIL)到0.91(95%CI 0.87-0.95,CFS)。
- 仅FRAIL与院内死亡升高相关(6.7% vs 1.0%,P=.031)。
- FRAIL和CFS与住院时间延长相关(分别为10[6.0-17.5] vs 8[5.0-14.0]天,P=.043;9[5.0-17.0] vs 7[4.25-11.75]天,P=.036)。
- CFS和FI与12个月死亡高度相关(CFS衰弱vs非衰弱32.9% vs 2.5%,P<.001;FI衰弱vs非衰弱30.6% vs 3.7%,P<.001)。
关键数值与推荐
- 相对FI的AUC:FRAIL 0.81(95%CI 0.72-0.90),CFS 0.91(95%CI 0.87-0.95)。
- 院内死亡:FRAIL衰弱组6.7% vs 非衰弱组1.0%(P=.031)。
- 12个月死亡:CFS衰弱组32.9% vs 非衰弱组2.5%(P<.001);FI衰弱组30.6% vs 非衰弱组3.7%(P<.001)。
- 12个月死亡OR(CFS,校正后)5.78(95%CI 3.19-10.48,P<.001);机构化和/或死亡OR 3.69(95%CI 2.31-5.88,P<.001)。
临床怎么用
- 住院老年患者可用CFS评估衰弱,其与FI一致性高且对12个月死亡和机构化预测力最强。
- 需关注院内死亡风险时可结合FRAIL评估,其与院内死亡升高相关。
- 衰弱评估有助于识别住院期间及出院后高风险老年人,辅助临床决策。
局限性
- 单中心研究,样本量210例,平均年龄89.4岁且女性占69.5%,外推需谨慎。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Data for the assessment of frailty in acutely ill hospitalized older adults remains limited. Using the Frailty Index (FI) as "gold standard," we compared (1) the diagnostic performance of 3 frailty measures (FRAIL, Clinical Frailty Scale [CFS], and Tilburg Frailty Indicator [TFI]) in identifying frailty, and (2) their ability to predict negative outcomes at 12 months after enrollment. DESIGN: Prospective cohort study. PARTICIPANTS: We recruited 210 patients (mean age 89.4 ± 4.6 years, 69.5% female), admitted to the Department of Geriatric Medicine in a 1300-bed tertiary hospital. MEASUREMENTS: Premorbid frailty status was determined. Data on comorbidities, severity of illness, functional status, and cognitive status were gathered. We compared area under receiver operator characteristic curves (AUC) for each frailty measure against the reference FI. Multiple logistic regression was used to examine the independent association between frailty and the outcomes of interest. RESULTS: Frailty prevalence estimates were 87.1% (FI), 81.0% (CFS), 80.0% (TFI), and 50.0% (FRAIL). AUC against FI ranged from 0.81 (95% confidence interval [CI] 0.72-0.90: FRAIL) to 0.91 (95% CI 0.87-0.95: CFS). Only FRAIL was associated with higher in-hospital mortality (6.7% vs 1.0%, P = .031). FRAIL and CFS were significantly associated with increased length of hospitalization (10 [6.0-17.5] vs 8 [5.0-14.0] days, P = .043 and 9 [5.0-17.0] vs 7 [4.25-11.75] days, P = .036, respectively). CFS and FI were highly associated with mortality at 12-month (CFS, frail vs nonfrail: 32.9% vs 2.5%, P < .001, and FI, frail vs nonfrail: 30.6% vs 3.7%, P < .001). CFS also conferred the greatest risk of 12-month mortality (odds ratio [OR] 5.78, 95% CI 3.19-10.48, P < .001) and composite outcomes of institutionalization and/or mortality (OR 3.69, 95% CI 2.31-5.88, P < .001), adjusted for age, sex, and severity of illness. CONCLUSION: Our study affirms the utility of frailty assessment tools among older persons in acute care. FRAIL conferred highest risk of in-hospital mortality. However, CFS had greatest risk of mortality and institutionalization within 12 months.
引用
- Chong E, Ho E, Baldevarona-Llego J, et al. Frailty in Hospitalized Older Adults: Comparing Different Frailty Measures in Predicting Short- and Long-term Patient Outcomes. J Am Med Dir Assoc. 2017. PMID: 29153536. doi:10.1016/j.jamda.2017.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。